Jeff Bezos invests in the quest for immortality

Jeff Bezos wants to delay ageing, quite literally. Multi-billionaire has become an investor in Altos Labs, an anti-aging technology startup, reports MIT Tech Review.

Altos Labs is studying the aging process and developing technology that can reprogram human cells to combat aging. The research is based on the developments of the Japanese scientist Yamanaka Shinyi, who received the Nobel Prize for his discoveries.

The center’s specialists plan to create a way to extend human life by 50 years.

Little is known about the company. The report said the start-up was set in the US and UK this year following a biotechnology-oriented conference that was held in the Los Altos Hills.

According to the MIT Tech Review, a securities disclosure filed in California in June indicates the company has raised at least $270 million (€227 million).

The company also reportedly plans to set up in multiple locations including San Diego, Japan, and Cambridge in the UK.

Bezos is said to have a fairly long-standing interest in longevity research, and he previously invested in an anti-aging company called Unity Biotechnology.

Do you think it’s a noble goal to pursue immortality? We would love to hear in the comments.

Unlock exclusive content with Anomalien PLUS+ Get access to PREMIUM articles, special features and AD FREE experience Learn More. Follow us on Facebook, Instagram, X (Twitter) and Telegram for BONUS content!
Default image
Jake Carter

Jake Carter is a journalist and a most prolific writer who has been fascinated by science and unexplained since childhood.

He is not afraid to challenge the official narratives and expose the cover-ups and lies that keep us in the dark. He is always eager to share his findings and insights with the readers of, a website he created in 2013.

Leave a Reply